6CM
IMUX icon

683 Capital Management’s Immunic IMUX Stock Holding History

683 Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.72M Buy
+245,000
New +$2.19M 0.25% 95
2025
Q3 		– Sell
-6,246
Closed -$43.6K – 151
2025
Q2 		$43.6K Sell
6,246
-83,754
-93% -$769K ﹤0.01% 128
2025
Q1 		$981K Buy
90,000
+20,000
+29% +$216K 0.1% 122
2024
Q4 		$700K Buy
70,000
+1,535
+2% +$19.3K 0.07% 129
2024
Q3 		$1.13M Sell
68,465
-1,465
-2% -$20.9K 0.12% 101
2024
Q2 		$776K Hold
69,930
– – 0.08% 105
2024
Q1 		$923K Buy
+69,930
New +$909K 0.09% 91

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return